GlassScriptPhysician profile
Brandt Michael Riley
NPI 1306064324
$872.34
in general payments reported to CMS, 2019-2025
15 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $34.11 · 2021: $99.37 · 2022: $135 · 2024: $72.77 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $252.59 | 2019-2025 | Constellation, Clareon |
| Glaukos Corporation | $126.89 | 2019-2024 | Idose |
| Rxsight INC | $112.04 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $85.38 | 2019-2020 | |
| Dompe US, INC. | $56.43 | 2021 | |
| Bausch & Lomb Americas INC. | $40.72 | 2022 | |
| Allergan, INC. | $37.38 | 2021-2022 | |
| The Cameron-Ehlen Group, INC. | $27.99 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $27.94 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $25.01 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $21.38 | 2024 | Healon Duet Pro |
| Lkc Technologies, INC. | $17.69 | 2024 | |
| Aerie Pharmaceuticals, INC. | $16.90 | 2021 | |
| Oyster Point Pharma, INC. | $15.08 | 2024 | Tyrvaya |
| New World Medical,INC. | $8.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandt Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.